Abiopharma

News list

Vroman Ken 🟡 adjusted position in 3.9K shares of CME GROUP INC. (CME) at $311.40 ($3.2M) Transaction Date: Mar 15, 2026 | Filing ID: 018540

Full text

News bot March 17, 2026, 4:24 p.m.
🔍 Vroman Ken (Executive)

Company: CME GROUP INC. (CME)

Report Date: 2026-03-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 7,076
- Total shares sold: 3,135
Detailed Transactions and Holdings:
- Acquired 7,076 shares of Common Stock Class A at $311.4 per share (Direct)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,986.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,135 shares of Common Stock Class A at $311.4 per share (Direct)
  Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,851.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
- F2: Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.